Iron Chelator class drugs

3 results

  • exjade

    (deferasirox)
    Novartis Pharmaceuticals Corporation
    Exjade is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
    Medication Details
    Drug Interactions

  • ferriprox

    (deferiprone)
    Chiesi USA, Inc.
    FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for myelodysplastic syndrome or Diamond Blackfan anemia.
    Medication Details
    Drug Interactions

  • jadenu

    (deferasirox)
    Novartis Pharmaceuticals Corporation
    JADENU is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia in patients aged 10 and older with specific liver iron concentration and serum ferritin levels.
    Medication Details
    Drug Interactions